These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 5243492)

  • 1. Cardiovascular effects of o,p'-DDD.
    Cueto C
    IMS Ind Med Surg; 1968 Jul; 37(7):520. PubMed ID: 5243492
    [No Abstract]   [Full Text] [Related]  

  • 2. Cardiovascular effects of o.p'-DDD.
    Cueto C
    IMS Ind Med Surg; 1970 Jan; 39(1):55-6. PubMed ID: 5263055
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of o,p-DDD on the secretion of 11- and 17-hydroxycorticosteroids in dogs during stress].
    Reznikov AG; Kravtsova EL
    Patol Fiziol Eksp Ter; 1970; 14(4):38-40. PubMed ID: 5508578
    [No Abstract]   [Full Text] [Related]  

  • 4. Enantioselective induction of cytotoxicity by o,p'-DDD in PC12 cells: implications of chirality in risk assessment of POPs metabolites.
    Wang C; Li Z; Zhang Q; Zhao M; Liu W
    Environ Sci Technol; 2013 Apr; 47(8):3909-17. PubMed ID: 23485034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medical treatment of canine hyperadrenocorticoidism with o,p'-DDD.
    Lorenz MD; Scott DW; Pulley LT
    Cornell Vet; 1973 Oct; 63(4):646-65. PubMed ID: 4748884
    [No Abstract]   [Full Text] [Related]  

  • 6. [The effect of o,p'-DDD (chloditane) on the secretion and metabolism of corticosteroids in chickens].
    Komisarenko VP; Kravchenko VI; Tron'ko MD; Turchin IS
    Fiziol Zh; 1971; 17(4):135-41. PubMed ID: 4344162
    [No Abstract]   [Full Text] [Related]  

  • 7. [Restorative processes in the adrenal cortex of dogs after administration of O,P'-DDD].
    Komissarenko VP; Gordienko VM; Reznikov AG
    Probl Endokrinol (Mosk); 1972; 18(3):74-81. PubMed ID: 5029293
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of O,N'=dichlorodiphenyldichloroethane and pertan in vitro on glutathione reductase activity in the adrenals of dogs and guinea pigs].
    Komissarenko VP; Chelnakova IS; Mikosha AS
    Biull Eksp Biol Med; 1978 Feb; 85(2):159-61. PubMed ID: 630087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytogenetic status of human lymphocytes after exposure to low concentrations of p,p'-DDT, and its metabolites (p,p'-DDE, and p,p'-DDD) in vitro.
    Gerić M; Ceraj-Cerić N; Gajski G; Vasilić Ž; Capuder Ž; Garaj-Vrhovac V
    Chemosphere; 2012 Jun; 87(11):1288-94. PubMed ID: 22354074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment with o,p'-DDD of inoperable forms of malignant adrenal gland neoplasms].
    Perevodchikova NI; Platinskiĭ LV; Kertsman VI
    Vopr Onkol; 1972; 18(11):24-9. PubMed ID: 4645074
    [No Abstract]   [Full Text] [Related]  

  • 11. [The effects of the adrenal cortex function inhibitor Chloditan (o,p'-DDD) on serum proteins].
    Vaniurikhina LT
    Fiziol Zh; 1972; 18(5):591-5. PubMed ID: 4656677
    [No Abstract]   [Full Text] [Related]  

  • 12. [Accumulation and elimination of o,p'-DDD in organs and tissues of guinea pigs and dogs].
    Korpachev VV
    Fiziol Zh; 1972; 18(5):585-90. PubMed ID: 4656676
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effect of o,p'-DDD on hydrocortisone metabolism in dogs and rats].
    Komisarenko VP; Tron'ko MD
    Fiziol Zh; 1973; 19(6):765-8. PubMed ID: 4787217
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of o,p'-DDD on transcortin-binding ability in dogs].
    Komissarenko VP; Mikosha AS; Tron'ko ND
    Fiziol Zh; 1970; 16(1):10-3. PubMed ID: 5488760
    [No Abstract]   [Full Text] [Related]  

  • 15. Anaerobic biodegradation of DDT residues (DDT, DDD, and DDE) in estuarine sediment.
    Huang HJ; Liu SM; Kuo CE
    J Environ Sci Health B; 2001 May; 36(3):273-88. PubMed ID: 11411851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Current concepts of the mechanism of action o,p'-DDD on the adrenal cortex function].
    Komisarenko VP; Reznikov OH; Mikosha OS
    Fiziol Zh; 1972; 18(5):579-84. PubMed ID: 4656675
    [No Abstract]   [Full Text] [Related]  

  • 17. [Dependence of the absorption of o,p'-DDD on the dose and drug form of the preparation].
    Korpachov VV
    Farm Zh; 1972; 27(3):64-6. PubMed ID: 4662820
    [No Abstract]   [Full Text] [Related]  

  • 18. [Sulfhydryl groups of proteins and non-protein compounds in some segments of the brain of dogs following administration of o,p'-DDD].
    Mestechkina AIa
    Farmakol Toksikol; 1972; 35(1):110-1. PubMed ID: 5020374
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect of o,p'-DDD on the binding ability of transcortin in dogs, rats, guinea pigs and chickens].
    Tron'ko MD; Kravchenko VI
    Fiziol Zh; 1971; 17(2):245-7. PubMed ID: 5565999
    [No Abstract]   [Full Text] [Related]  

  • 20. Systemic availability of o,p'-DDD in normal dogs, fasted and fed, and in dogs with hyperadrenocorticism.
    Watson AD; Rijnberk A; Moolenaar AJ
    Res Vet Sci; 1987 Sep; 43(2):160-5. PubMed ID: 3685628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.